{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:32:40Z","timestamp":1789651960328,"version":"4.0.0"},"reference-count":30,"publisher":"The Editorial Office of Gut and Liver","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut Liver"],"published-print":{"date-parts":[[2015,5,23]]},"DOI":"10.5009\/gnl14170","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T08:40:17Z","timestamp":1417682417000},"source":"Crossref","is-referenced-by-count":12,"title":["Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy"],"prefix":"10.5009","volume":"9","author":[{"given":"Jin Chang","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Teik","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Ghon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2920","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy, D","year":"2004","journal-title":"J Viral Hepat"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen, CJ","year":"2006","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje, UH","year":"2006","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","article-title":"Risk and predictors of mortality associated with chronic hepatitis B infection","volume":"5","author":"Iloeje, UH","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/135965350701200816","article-title":"Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease","volume":"12","author":"Yuen, MF","year":"2007","journal-title":"Antivir Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw, YF","year":"2004","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.1840400418","article-title":"Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine","volume":"40","author":"Di Marco, V","year":"2004","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw, YF","year":"2009","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/MCG.0b013e31821f8bdf","article-title":"Comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B virus infection: two-year follow-up data","volume":"45","author":"Yoon, EL","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin, P","year":"2003","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis, SJ","year":"2003","journal-title":"N Engl J Med"},{"key":"ref12","first-page":"1419","article-title":"Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients","volume":"38","author":"Schiff, ER","year":"2003","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.21534","article-title":"Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B","volume":"45","author":"Rapti, I","year":"2007","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2007.08.079","article-title":"Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients","volume":"133","author":"Lampertico, P","year":"2007","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep.22323","article-title":"Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks","volume":"48","author":"Sherman, M","year":"2008","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang, TT","year":"2006","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","article-title":"Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B","volume":"354","author":"Lai, CL","year":"2006","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin, P","year":"2008","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach","volume":"134","author":"Pawlotsky, JM","year":"2008","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3851\/IMP1702","article-title":"Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B","volume":"16","author":"Han, KH","year":"2011","journal-title":"Antivir Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","article-title":"Revision and update on clinical practice guideline for liver cirrhosis","volume":"18","author":"Suk, KT","year":"2012","journal-title":"Korean J Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":",","year":"2012","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3350\/cmh.2012.18.2.109","article-title":"KASL clinical practice guidelines: management of chronic hepatitis B","volume":"18","author":",","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag, JL","year":"2003","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis, SJ","year":"2006","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1872-034X.2012.01038.x","article-title":"Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B","volume":"42","author":"Toyama, T","year":"2012","journal-title":"Hepatol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong, GL","year":"2013","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka, T","year":"2013","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1440-1746.2012.07167.x","article-title":"Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents","volume":"27","author":"Kim, CH","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis, GV","year":"2010","journal-title":"J Hepatol"}],"container-title":["Gut and Liver"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/ekjg\/ekjg009-03-16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T21:33:44Z","timestamp":1650749624000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.gutnliver.org\/journal\/view.html?doi=10.5009\/gnl14170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,23]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5,23]]}},"alternative-id":["10.5009\/gnl14170"],"URL":"https:\/\/doi.org\/10.5009\/gnl14170","relation":{},"ISSN":["1976-2283","2005-1212"],"issn-type":[{"value":"1976-2283","type":"print"},{"value":"2005-1212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,23]]}}}